Akira Takakura Selected Research

Akira Takakura Research Topics

Disease

9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2009
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2017 - 02/2009
4	Infections 08/2015 - 04/2006
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2018
2	Communicable Diseases (Infectious Diseases) 05/2021 - 11/2019
2	Hypertension (High Blood Pressure) 01/2017 - 07/2011
2	Hypercapnia 12/2016 - 01/2015
2	Diarrhea 03/2012 - 10/2008
2	Lung Neoplasms (Lung Cancer) 01/2012 - 02/2009
1	Adenocarcinoma of Lung 11/2018
1	Neoplasms (Cancer) 11/2018
1	Neoplasm Metastasis (Metastasis) 11/2018
1	Vascular Diseases (Vascular Disease) 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Leukopenia 08/2015
1	Erysipelas 08/2015
1	Eosinophilia 03/2015
1	Asthma (Bronchial Asthma) 01/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2015
1	Sepsis (Septicemia) 01/2015
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 10/2013
1	Small Cell Carcinoma 12/2012
1	Neutropenia 06/2012
1	Dyspnea (Shortness of Breath) 07/2011
1	Pneumonia (Pneumonitis) 07/2011
1	Bronchiectasis 07/2011
1	Coronavirus Infections 05/2011
1	Thymus Neoplasms (Thymus Neoplasm) 11/2010
1	Carcinoma (Carcinomatosis) 09/2009
1	Parvoviridae Infections (Parvovirus Infection) 04/2006

Drug/Important Bio-Agent (IBA)

7	amrubicinIBA 03/2017 - 02/2009
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 10/2008
4	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 11/2010
3	AntibodiesIBA 05/2021 - 10/2013
2	Aminophylline (Carine)FDA LinkGeneric 12/2016 - 01/2015
2	Gefitinib (Iressa)FDA Link 01/2015 - 08/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2012 - 11/2010
2	7-ethyl-10-hydroxycamptothecin beta-glucuronideIBA 03/2012 - 10/2008
2	GlucuronidaseIBA 03/2012 - 10/2008
2	Pemetrexed (MTA)FDA Link 01/2012 - 01/2012
2	AntigensIBA 05/2011 - 04/2006
1	Immune Checkpoint InhibitorsIBA 11/2018
1	NivolumabIBA 11/2018
1	B7-H1 AntigenIBA 11/2018
1	CollagenIBA 01/2018
1	130-nm albumin-bound paclitaxelIBA 01/2018
1	AsbestosIBA 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2015
1	Immunoglobulin E (IgE)IBA 03/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015
1	Theophylline (Theon)FDA LinkGeneric 01/2015
1	ErbB Receptors (EGF Receptor)IBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	Bevacizumab (Avastin)FDA Link 12/2012
1	Topoisomerase I InhibitorsIBA 06/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2012
1	Topoisomerase II InhibitorsIBA 06/2012
1	Thymidylate SynthaseIBA 01/2012
1	Docetaxel (Taxotere)FDA Link 01/2012
1	Valsartan (Vals)FDA Link 07/2011
1	Angiotensin Receptor AntagonistsIBA 07/2011
1	Warfarin (Coumadin)FDA LinkGeneric 08/2009
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 04/2009
1	AnthracyclinesIBA 02/2009
1	EnzymesIBA 06/2007
1	ImmunosorbentsIBA 06/2007
1	Proteins (Proteins, Gene)FDA Link 04/2006
1	Capsid Proteins (Capsid Protein)IBA 04/2006

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2022 - 09/2009
5	Therapeutics 08/2015 - 01/2012
1	Radiotherapy 01/2017
1	Induction Chemotherapy 01/2017
1	Salvage Therapy 01/2012
1	Traction 07/2011